Your browser doesn't support javascript.
loading
Are the cut-offs of the rheumatoid factor and anti-cyclic citrullinated peptide antibody different to distinguish rheumatoid arthritis from their primary differential diagnoses?
Pineda-Sic, Rita Angélica; Vega-Morales, David; Santoyo-Fexas, Leticia; Garza-Elizondo, Mario Alberto; Mendiola-Jiménez, Andrés; González Marquez, Karina Itzel; Carrillo-Haro, Berenice.
Afiliación
  • Pineda-Sic RA; Rheumatology Department, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Vega-Morales D; Rheumatology Department, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Santoyo-Fexas L; Rheumatology Department, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Garza-Elizondo MA; Rheumatology Department, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Mendiola-Jiménez A; Rheumatology Department, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • González Marquez KI; Rheumatology Department, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Carrillo-Haro B; School of Medicine and Health Sciences, Instituto Tecnologico y de Estudios Superiores de Monterrey, Monterrey, Mexico.
Int J Immunogenet ; 51(1): 1-9, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37933209
OBJECTIVE: Rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (anti-CCP) are commonly used for diagnosis of rheumatoid arthritis (RA), although other rheumatic diseases with arthritis can test positive. This study aimed to determine the cutoff values for RF and anti-CCP with the best diagnostic performance in a sample of patients with RA, compared with other rheumatic diseases. METHODS: This was a descriptive, prospective study. EUROINMMUN enzyme-linked immunosorbent assays for RF isotypes immunoglobulin (Ig) A (IgA), IgG and IgM and third-generation assay IgG for anti-CCP were used in serum samples of patients with RA, other rheumatic diseases and healthy subjects. The cutoff with the best diagnostic performance was determined by the Youden Index and receiver operating characteristic analysis Results: Three hundred and thirty-two serum samples were analysed. The cutoffs proposed in our population were for RF in RA patients versus other rheumatic diseases, and healthy subjects IgM 135 IU/mL, for each disease, compared with RA, were psoriatic arthritis (Psa) IgA 47.2 IU/mL, clinically suspicious arthralgia (CSA) IgA 39.5 IU/mL, primary Sjögren's syndrome (pSS) IgM 180.6 IU/mL, systemic lupus erythematosus (SLE) IgA 42.6 IU/mL, primary fibromyalgia (pFM) IgM 68.6 IU/mL, osteoarthritis (OA) IgM 48 IU/mL, gout IgM 117 IU/mL and healthy IgM 16.3 IU/mL. For anti-CCP, in RA patients versus other rheumatic diseases, and healthy subjects 6.95 IU/mL, for each disease, compared with RA, were Psa 6.8 IU/mL, CSA 9.95 IU/mL, pSS 20.7 IU/mL, SLE 6 IU /mL, pFM 11.8 IU/mL, OA 11.9 IU/mL, gout 5 IU/mL and healthy 5 IU/mL. CONCLUSION: Irrespective of the manufacturer's suggested cutoff, the RA versus differential diagnosis cutoffs must be considered.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Enfermedades Reumáticas / Gota / Lupus Eritematoso Sistémico Límite: Humans Idioma: En Revista: Int J Immunogenet Asunto de la revista: ALERGIA E IMUNOLOGIA / GENETICA Año: 2024 Tipo del documento: Article País de afiliación: México Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Enfermedades Reumáticas / Gota / Lupus Eritematoso Sistémico Límite: Humans Idioma: En Revista: Int J Immunogenet Asunto de la revista: ALERGIA E IMUNOLOGIA / GENETICA Año: 2024 Tipo del documento: Article País de afiliación: México Pais de publicación: Reino Unido